Detalhe da pesquisa
1.
Toward a more patient-centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS).
Hemasphere;
8(5): e69, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38774655
2.
Ribosome subunit attrition and activation of the p53-MDM4 axis dominate the response of MLL-rearranged cancer cells to WDR5 WIN site inhibition.
Elife;
122024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38682900
3.
Clonal Hematopoiesis and Inflammation in the VasculaturE (CHIVE): a prospective, longitudinal cohort and biorepository.
Blood Adv;
2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38608257
4.
Cost-Effective and Scalable Clonal Hematopoiesis Assay Provides Insight into Clonal Dynamics.
J Mol Diagn;
2024 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38588769
5.
Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes.
Blood;
2024 04 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38687605
6.
Repair of leukemia-associated single nucleotide variants via interallelic gene conversion.
bioRxiv;
2024 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38659776
7.
Interoperability of phenome-wide multimorbidity patterns: a comparative study of two large-scale EHR systems.
medRxiv;
2024 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38585743
8.
Solid organ transplant recipients exhibit more TET2-mutant clonal hematopoiesis of indeterminate potential not driven by increased transplantation risk.
Clin Cancer Res;
2024 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38551504
9.
Multiomic Profiling of Human Clonal Hematopoiesis Reveals Genotype and Cell-Specific Inflammatory Pathway Activation.
Blood Adv;
2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38507736
10.
Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid Leukemia.
Cancer Res;
84(7): 1101-1114, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38285895
11.
Driver mutation zygosity is a critical factor in predicting clonal hematopoiesis transformation risk.
Blood Cancer J;
14(1): 6, 2024 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38225345
12.
A randomized, double-blind study of zinpentraxin alfa in patients with myelofibrosis who were previously treated with or ineligible for ruxolitinib: Stage 2 of a phase II trial.
Haematologica;
2024 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38268448
13.
Ribosome subunit attrition and activation of the p53-MDM4 axis dominate the response of MLL-rearranged cancer cells to WDR5 WIN site inhibition.
bioRxiv;
2024 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37546802
14.
Imetelstat in patients with lower-risk myelodysplastic syndromes who have relapsed or are refractory to erythropoiesis-stimulating agents (IMerge): a multinational, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet;
403(10423): 249-260, 2024 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38048786
15.
Oral decitabine-cedazuridine versus intravenous decitabine for myelodysplastic syndromes and chronic myelomonocytic leukaemia (ASCERTAIN): a registrational, randomised, crossover, pharmacokinetics, phase 3 study.
Lancet Haematol;
11(1): e15-e26, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38135371
16.
TLR3 agonism augments CD47 inhibition in acute myeloid leukemia.
Haematologica;
2023 Dec 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38152031
17.
LAIR-1 agonism as a therapy for acute myeloid leukemia.
J Clin Invest;
133(22)2023 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37966113
18.
Cost-effective and scalable clonal hematopoiesis assay provides insight into clonal dynamics.
medRxiv;
2023 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37986782
19.
Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS).
Blood Rev;
62: 101128, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37704469
20.
PheMIME: An Interactive Web App and Knowledge Base for Phenome-Wide, Multi-Institutional Multimorbidity Analysis.
medRxiv;
2023 Jul 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37547012